论文部分内容阅读
目的分析胺碘酮联合倍他乐克治疗室性心律失常的疗效。方法选取我院2015年2月~2016年2月收治的室性心律失常患者84例作为研究对象,运用双色球随机分组法分为观察组和对照组,各42例。对照组患者给予胺碘酮治疗,观察组患者采用胺碘酮联合倍他乐克治疗,观察两组患者治疗疗效。结果观察组患者治疗总有效率为95.24%,高于对照组的80.95%;观察组患者室性心律失常发作次数少于对照组,差异有统计学意义(P<0.05),不良反应发生率比较,差异无统计学意义(P>0.05)。结论针对室性心律失常患者,采用胺碘酮联合倍他乐克治疗,可有效缓解临床症状,减轻患者不适,提高治疗疗效,且不良反应少,安全性更高,值得临床推广应用。
Objective To analyze the efficacy of amiodarone combined with metoprolol in the treatment of ventricular arrhythmia. Methods Eighty-four patients with ventricular arrhythmia admitted from February 2015 to February 2016 in our hospital were selected as the research objects and divided into observation group and control group with 42 cases in each group. Patients in the control group were treated with amiodarone. Patients in the observation group were treated with amiodarone and metoprolol. The curative effect was observed in both groups. Results The total effective rate of observation group was 95.24%, higher than 80.95% of control group. The incidence of ventricular arrhythmia in observation group was less than that of control group (P <0.05), and the incidence of adverse reactions , The difference was not statistically significant (P> 0.05). Conclusions For patients with ventricular arrhythmia, the combination of amiodarone and metoprolol can effectively relieve the clinical symptoms, relieve the discomfort of patients and improve the curative effect with less adverse reactions and higher safety, which is worthy of clinical application.